Literature DB >> 89883

Non-operative arterial embolisation in primary liver tumours.

P G Wheeler, W Melia, P Dubbins, B Jones, H Nunnerley, P Johnson, R Williams.   

Abstract

Three patients with primary hepatic tumours were treated by selective arterial embolisation with gelatin-foam fragments to induce necrosis. In the two with histologically proved hepatocellular carcinoma ultrasonography suggested that necrosis had been induced, as did the rapid initial falls in serum alpha-fetoprotein concentration by 95 and 81% of the original values respectively. Treatment was continued with a course of adriamycin, and both patients remained well and symptom free at 10 and 12 months. In the third patient, who had an expanding and highly vascular benign hepatic adenoma associated with use of a contraceptive pill, embolisation obliterated the tumour mass. Tumour embolisation should be regarded as only the first step in managing hepatocellular carcinoma and as a means of reducing appreciably the viable tumour mass before chemotherapy. It may be used as the primary and definitive treatment in patients with benign liver tumours.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89883      PMCID: PMC1595546          DOI: 10.1136/bmj.2.6184.242

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  The blood supply of neoplasms in the liver.

Authors:  C BREEDIS; G YOUNG
Journal:  Am J Pathol       Date:  1954 Sep-Oct       Impact factor: 4.307

2.  Transcatheter occlusion of abdominal tumors.

Authors:  H M Goldstein; S Wallace; J H Anderson; R L Bree; C Gianturco
Journal:  Radiology       Date:  1976-09       Impact factor: 11.105

3.  Radiology now. Therapeutic angiographic embolization.

Authors:  R Dick
Journal:  Br J Radiol       Date:  1977-04       Impact factor: 3.039

4.  Therapeutic embolization.

Authors:  D J Allison
Journal:  Br J Hosp Med       Date:  1978-12

5.  Occlusion of the hepatic artery in man.

Authors:  D K Kim; D W Kinne; J G Fortner
Journal:  Surg Gynecol Obstet       Date:  1973-06

6.  Treatment of hepatic tumours by ligation of the hepatic artery and infusion of cytotoxic drugs.

Authors:  I M Murray-Lyon
Journal:  J R Coll Surg Edinb       Date:  1972-05

7.  Induction of remission in hepatocellular carcinoma with doxorubicin.

Authors:  P J Johnson; R Williams; H Thomas; S Sherlock; I M Murray-Lyon
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

8.  Treatment of carcinoid liver metastases by hepatic-artery embolisation.

Authors:  D J Allison; I M Modlin; W J Jenkins
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

  8 in total
  29 in total

1.  Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Authors:  K Yamamoto; M Masuzawa; M Kato; T Okuyama; K Tamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; A Tsubota; I Koida; M Kobayashi; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  The role of surgery in the management of unusual complications of transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K S Jeng; H J Ching
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

Review 4.  Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.

Authors:  R Duran; J Chapiro; R E Schernthaner; J-F H Geschwind
Journal:  Br J Radiol       Date:  2015-05-15       Impact factor: 3.039

5.  Evaluation by ultrasonography of arterial embolization therapy for hepatocellular carcinoma.

Authors:  H Ohishi; H Uchida; Y Kurosaki; H Yoshimura; S Ohue; M Katsuragi; N Matsuo; Y Hosogi
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

6.  Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma.

Authors:  P Attali; D Houssin; A Roche; C Buffet; H Bismuth; J P Etienne
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

7.  Hepatic resection for hepatocellular carcinoma.

Authors:  M Suenaga; A Nakao; A Harada; T Nonami; Y Okada; H Sugiura; S Uehara; H Takagi
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

8.  Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.

Authors:  N Nakao; H Uchida; K Kamino; Y Nishimura; H Ohishi; Y Takayasu; H Nakamura; C Kuroda; M Fujita; H Yoshioka
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: a comparison with transcatheter arterial chemoembolization.

Authors:  K S Jeng; F S Yang; H J Chiang; I Ohta
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

10.  Surgical management of spontaneous ruptured hepatocellular adenoma.

Authors:  Marcelo Augusto Fontenelle Ribeiro Junior; Eleazar Chaib; William Abrão Saad; Luiz Augusto Carneiro D'Albuquerque; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.